1. Home
  2. CLYM
  3. CLYM News

Latest CLIMB BIO INC (CLYM) News on March 29, 2025

Climb Bio to Present at the 24th Annual Needham Virtual Healthcare Conference
CLYM

GlobeNewswire

2 days ago

Climb Bio to Present at the 24th Annual Needham Virtual Healthcare Conference

Climb Bio Fueled Up with Cash, Poised for More Milestones in ’25 – Quarterly Update Report
CLYM

Exec Edge

3 days ago

Climb Bio Fueled Up with Cash, Poised for More Milestones in ’25 – Quarterly Update Report

Climb Bio Reports Fourth Quarter and Year-End 2024 Financial Results and Provides Business Updates
CLYM

GlobeNewswire

4 days ago

Climb Bio Reports Fourth Quarter and Year-End 2024 Financial Results and Provides Business Updates

Climb Bio: Meet The Newest Star in Autoimmune Disease Treatment – Initiation Report
CLYM

Exec Edge

9 days ago

Climb Bio: Meet The Newest Star in Autoimmune Disease Treatment – Initiation Report

Climb Bio to Present at Upcoming Investor Conferences
CLYM

GlobeNewswire

a month ago

Climb Bio to Present at Upcoming Investor Conferences

Climb Bio Appoints Perrin Wilson, Ph.D., as Chief Business Officer
CLYM

GlobeNewswire

a month ago

Climb Bio Appoints Perrin Wilson, Ph.D., as Chief Business Officer

Climb Bio to Present at the Oppenheimer 35th Annual Healthcare Life Sciences Conference
CLYM

GlobeNewswire

2 months ago

Climb Bio to Present at the Oppenheimer 35th Annual Healthcare Life Sciences Conference

Climb Bio Expands Pipeline Through an Exclusive License to Develop and Commercialize an Antibody Targeting the APRIL Pathway for IgA Nephropathy
CLYM

GlobeNewswire

3 months ago

Climb Bio Expands Pipeline Through an Exclusive License to Develop and Commercialize an Antibody Targeting the APRIL Pathway for IgA Nephropathy

Climb Bio to be Added to the Nasdaq Biotechnology Index
CLYM

GlobeNewswire

3 months ago

Climb Bio to be Added to the Nasdaq Biotechnology Index

Climb Bio Reports Third Quarter 2024 Financial Results and Business Highlights
CLYM

GlobeNewswire

5 months ago

Climb Bio Reports Third Quarter 2024 Financial Results and Business Highlights

Climb Bio Appoints Douglas E. Williams, Ph.D., as Chair of the Board
CLYM

GlobeNewswire

5 months ago

Climb Bio Appoints Douglas E. Williams, Ph.D., as Chair of the Board

Climb Bio to Present at Upcoming Investor Conferences
CLYM

GlobeNewswire

5 months ago

Climb Bio to Present at Upcoming Investor Conferences

Climb Bio to Provide Budoprutug Development Strategy and Corporate Update at Virtual Investor Event
CLYM

GlobeNewswire

5 months ago

Climb Bio to Provide Budoprutug Development Strategy and Corporate Update at Virtual Investor Event

Climb Bio Announces Abstract Selected for Presentation at the American Society of Nephrology Kidney Week 2024
CLYM

GlobeNewswire

6 months ago

Climb Bio Announces Abstract Selected for Presentation at the American Society of Nephrology Kidney Week 2024

Climb Bio to Present at William Blair’s Upcoming Conference Event on Transforming Autoimmune Diseases by Targeting CD19
CLYM

GlobeNewswire

6 months ago

Climb Bio to Present at William Blair’s Upcoming Conference Event on Transforming Autoimmune Diseases by Targeting CD19

Share on Social Networks: